Xtl Biopharmaceuticals XTLB
NASDAQ XTLB
$2.15 -0.10 (-4.44%)
At close: Oct 2, 2026 · 4:00 PM EDT

Xtl Biopharmaceuticals (XTLB) Gains from Investment Securities (2013)

Updated

Xtl Biopharmaceuticals (XTLB) posted Gains from Investment Securities of $330,000 for the quarter ended Dec 31, 2013, down 87.9% from the prior quarter.

Analysis

Xtl Biopharmaceuticals (XTLB) Gains from Investment Securities (2013) Analysis & Trends

For the year ended Dec 31, 2013, Xtl Biopharmaceuticals' Gains from Investment Securities came in at $3.05 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Xtl Biopharmaceuticals 2.03 Bn 2.03 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 330,000.00
Sep 30, 2013 2.72 Mn
API Access

Xtl Biopharmaceuticals Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=XTLB&period=max&api_key=YOUR_API_KEY